It was reported that an acculink stent was implanted in a right internal carotid artery and the same day, the patient had a non-occlusive deep vein thrombosis (dvt) (ischemia) and supraventricular tachycardia (svt) (atrial tachycardia).Xarelto medication was given and both the dvt and svt resolved approximately one month later.Additionally, approximately 11 months after the index procedure, on (b)(6) 2014 there was in-stent restenosis found of the target lesion.The patient was hospitalized and an endarterectomy was done on (b)(6) 2014 and the implanted acculink stent was removed from the patients anatomy.Reportedly, the patient stopped her plavix 3 months prior.There was no additional information provided.
|
(b)(4).Evaluation summary: the stent was returned for analysis.The reported patient effects could not be confirmed with the returned stent.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.The stent implant was sent to the fluoroscopy lab for evaluation.The fluoroscopy image was review by a abbott vascular clinical specialist.The results note that there are two stents in the image; the larger stent is located in the common carotid.The second is in the internal carotid.At the location of overlap the stents are constricted.It appears that tissue and possibly calcium are restricting full stent expansion.There was no reported device malfunction.The reported patient effect of stenosis is a known observed and potential patient effects as listed in the rx acculink, domestic, instructions for use.Although a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency.Based on the information reviewed, there is no indication of a product deficiency.
|